A subanalysis of Taiwanese patients from ODYSSEY South Korea and Taiwan study evaluating the efficacy and safety of alirocumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A subanalysis of Taiwanese patients from ODYSSEY South Korea and Taiwan study evaluating the efficacy and safety of alirocumab

Published:2019-04 Issue:4 Volume:82 Page:265-271
ISSN:1726-4901
Container-title:Journal of the Chinese Medical Association
language:en
Short-container-title:

Author:

Chao Ting-Hsing,Hsiao Pi-Jung,Liu Ming-En,Wu Chiung-Jen,Chiang Fu-Tien,Chen Zhih-Cherng,Chen Ching-Pei,Yeh Hung-I,Lee Tsong-Hai,Chiang Chern-En

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference44 articles.

1. Trends in the incidence and management of acute myocardial infarction from 1999 to 2008: get with the guidelines performance measures in Taiwan.;Lee;J Am Heart Assoc,2014

2. The temporal trends of incidence, treatment, and in-hospital mortality of acute myocardial infarction over 15 years in a Taiwanese population.;Yin;Int J Cardiol,2016

3. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.;Baigent;Lancet,2010

4. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study.;Sharrett;Circulation,2001

5. 2016 ESC/EAS guidelines for the management of dyslipidaemias.;Catapano;Eur Heart J,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of PCSK9 Inhibitors on Lipoprotein(a): A Meta-analysis and Meta-regression of Randomized Controlled Trials;2024-07-11

2. Efficacy and Safety of Inclisiran, Alirocumab, Evolocumab, and Evinacumab in Lipid-Lowering: A Network Meta-Analysis;2024-04-17

3. Real-World Data on Comparison of Lipid-Lowering Effects between Alirocumab and Evolocumab in Patients with Hypercholesterolemia;ACTA CARDIOL SIN;2022

4. Familial hypercholesterolemia in Southeast and East Asia;American Journal of Preventive Cardiology;2021-06

5. Insights on the efficacy and safety of PCSK-9 inhibitor in Taiwanese patients;Journal of the Chinese Medical Association;2019-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3